Signaling from MARK to tau: Regulation, cytoskeletal crosstalk, and pathological phosphorylation

Neurodegenerative Diseases

Volumn 3, Issue 4-5, 2006, Pages 207-217

  Timm, T ^a   Matenia, D ^a   Li, X Y ^a   Griesshaber, B ^a   Mandelkow, E M ^a  

^a MAX PLANCK UNIT FOR STRUCTURAL MOLECULAR BIOLOGY   (Germany)

Author keywords

Actin; Microtubules; p21 activated kinase; Phosphorylation of tau

Indexed keywords

MICROTUBULE AFFINITY REGULATING KINASE; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; HUMAN; HUMAN CELL; MICROTUBULE; MOLECULAR INTERACTION; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TAUOPATHY;

ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CYTOSKELETON; ENZYME ACTIVATION; HUMANS; MICROTUBULES; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TAU PROTEINS; TRANSFECTION;

EID: 33750146478     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000095258     Document Type: Conference Paper

References (54)

1. Augustinack JC, Schneider A, Mandelkow EM, Hyman B: Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002;103:26-35.
2. Drewes G, Ebneth A, Preuss U, Mandelkow E-M, Mandelkow E: MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 1997;89:297-308.
3. Pellettieri J, Seydoux G: Anterior-posterior polarity in C. elegans and Drosophila - PAR-allels and differences. Science 2002;298:1946-1950.
4. Macara IG: Par proteins: partners in polarization. Curr Biol 2004:14;R160-R162.
5. Biernat J, Wu YZ, Timm T, Zheng-Fischhofer Q, Mandelkow E, Meijer L, Mandelkow EM: Protein kinase MARK/par-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol Biol Cell 2002;13:4013-4028.
6. Huse M, Kuriyan J: The conformational plasticity of protein kinases. Cell 2002;109:275-282.
7. Panneerselvam S, Marx A, Mandelkow EM, Mandelkow E: Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Parl. Structure 2006;14:173-183.
8. Benton R, Palacios IM, St. Johnston D: Drosophila 14-3-3/PAR-5 is an essential mediator of PAR-1 function in axis formation. Dev Cell 2002;3:659-671.
9. Hurov J, Watkins J, Piwnica-Worms H: Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. Curr Biol 2004;14:736-741.
10. Suzuki A, Hirata M, Kamimura K, Maniwa R, Yamanaka T, Mizuno K, Kishikawa M, Hirose H, Amano Y, Izumi N, Miwa Y, Ohno S: aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr Biol 2004;14:1425-1435.
11. Elbert M, Rossi G, Brennwald P: The yeast Par-1 homologs Kin1 and Kin2 show genetic and physical interactions with components of the exocytic machinery. Mol Biol Cell 2005;16:532-549.
12. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S: The protein kinase complement of the human genome. Science 2002;298:1912-1934.
13. Dan I, Watanabe NM, Kusumi A: The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol 2001;11:220-230.
14. Chen Z, Hutchison M, Cobb MH: Isolation of the protein kinase TAO2 and identification of its mitogen-activated protein kinase/extracellular signal-regulated kinase kinase binding domain. J Biol Chem 1999;274:28803-28807.
15. Tassi E, Biesova Z, Di Fiore PP, Gutkind JS, Wong WT: Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor. J Biol Chem 1999;274:33287-33295.
16. Chen Z, Raman M, Chen L, Lee SF, Gilman AG, Cobb MH: TAO (thousand-and-one amino acid) protein kinases mediate signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors. J Biol Chem 2003;278:22278-22283.
17. Hutchison M, Berman KS, Cobb MH: Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. J Biol Chem 1998;273:28625-28632.
18. Jenkins SM, Johnson GV: Microtubule/MAP-affinity regulating kinase (MARK) is activated by phenylarsine oxide in situ and phosphorylates tau within its microtubule-binding domain. J Neurochem 2000;74:1463-1468.
19. Brown AJ, Hutchings C, Burke JF, Mayne LV: Application of a rapid method (targeted display) for the identification of differentially expressed mRNAs following NGF-induced neuronal differentiation in PC12 cells. Mol Cell Neurosci 1999;13:119-130.
20. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L: A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994;367:40-46.
21. Etienne-Manneville S, Hall A: Rho GTPases in cell biology. Nature 2002;420:629-635.
22. Jaffer ZM, Chernoff J: p21-activated kinases: three more join the Pak. Int J Biochem Cell Biol 2002;34:713-717.
23. Bokoch GM: Biology of the p21-activated kinases. Annu Rev Biochem 2003;72:743-781.
24. Hofmann C, Shepelev M, Chernoff J: The genetics of Pak. J Cell Sci 2004;117:4343-4354.
25. Dan C, Nath N, Liberto M, Minden A: PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol Cell Biol 2002;22:567-577.
26. Pandey A, Dan I, Kristiansen TZ, Watanabe NM, Voldby J, Kajikawa E, Khosravi-Far R, Blagoev B, Mann M: Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene 2002;30:3939-3948.
27. Ching YP, Leong VY, Wong CM, Kung HF: Identification of an autoinhibitory domain of p21-activated protein kinase 5. J Biol Chem 2003;278:33621-33624.
28. Bryan B, Kumar V, Stafford LJ, Cai Y, Wu G, Liu M: GEFT, a rho family guanine nucleotide exchange factor, regulates neurite outgrowth and dendritic spine formation. J Biol Chem 2004;279:45824-45832.
29. Timm T, Li XY, Biernat J, Jiao J, Mandelkow E, Vandekerckhove J, Mandelkow EM: MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J 2003;22:5090-5101.
30. Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E: MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 2004;167:99-110.
31. Matenia D, Griesshaber B, Li XY, Thiessen A, Johne C, Jiao J, Mandelkow E, Mandelkow EM: PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin. Mol Biol Cell 2005;16:4410-4422.
32. Braak H, Braak E: Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1:213-216.
33. Lee VM, Goedert M, Trojanowski JQ: Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-1159.
34. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM: Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002;156:1051-1063.
35. Mandelkow EM, Mandelkow E: Tau in Alzheimer's disease. Trends Cell Biol 1998;8:425-427.
36. von Bergen M, Li L, Mandelkow E: Intrinsic fluorescent detection of tau conformation and aggregation. Methods Mol Biol 2005;299:175-184.
37. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E: Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 1993;11:153-163.
38. Seubert P, Mawaldewan M, Barbour R, Jakes R, Goedert M, Johnson GVW, Litersky J, Schenk D, Lieberburg I, Trojanowski J, Lee VMY: Detection of phosphorylated Ser(262) in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 1995;270:18917-18922.
39. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Titani K, Ihara Y: Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 1995;270:823-829.
40. Chin JY, Knowles RB, Schneider A, Drewes G, Mandelkow EM, Hyman BT: Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study. J Neuropathol Exp Neurol 2000;59:966-971.
41. Kemphues K: PARsing embryonic polarity. Cell 2000;101:345-348.
42. Cohen D, Brennwald PJ, Rodriguez-Boulan E, Müsch A: Mammalian PAR-1 determines epithelial lumen polarity by organizing the microtubule cytoskeleton. J Cell Biol 2004;164:717-727.
43. Adams JA: Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model? Biochemistry 2003;42:601-607.
44. Raman M, Cobb MH: MAP kinase modules: many roads home. Curr Biol 2003;13:R886-R888.
45. Moore TM, Garg R, Johnson C, Coptcoat MJ, Ridley AJ, Morris JD: PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization. J Biol Chem 2000;275:4311-4322.
46. Kosik KS, Orecchio LD, Bakalis S, Neve RL: Developmentally regulated expression of specific tau sequences. Neuron 1989;2:1389-1397.
47. Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT: PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 2001;3:628-636.
48. Cotteret S, Jaffer ZM, Beeser A, Chernoff J: p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol Cell Biol 2003;23:5526-5539.
49. Schneider A, Laage R, von Ahsen O, Fischer A, Rossner M, Scheck S, Grunewald S, Kuner R, Weber D, Kruger C, Klaussner B, Gotz B, Hiemisch H, Newrzella D, Martin-Villalba A, Bach A, Schwaninger M: Identification of regulated genes during permanent focal cerebral ischaemia: characterization of the protein kinase 9b5/MARKL1/MARK4. J Neurochem 2004;88:1114-1126.
50. Hueso M, Beltran V, Moreso F, Ciriero E, Fulladosa X, Grinyo JM, Seron D, Navarro E: Splicing alterations in human renal allografts: detection of a new splice variant of protein kinase Par1/Emk1 whose expression is associated with an increase of inflammation in protocol biopsies of transplanted patients. Biochim Biophys Acta 2004;24:58-65.
51. Kato T, Satoh S, Okabe H, Kitahara O, Ono K, Kihara C, Tanaka T, Tsunoda T, Yamaoka Y, Nakamura Y, Furukawa Y: Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis. Neoplasia 2001;3:4-9.
52. Tochio N, Koshiba S, Inoue M, Kigawa T, Yokoyama S: Solution structure of kinase associated domain 1 of mouse MAP/microtubule affinity-regulating kinase 3. http://www.pdb.org 2003;PDB 1v5s.
53. Small JV, Kaverina I: Microtubules meet substrate adhesions to arrange cell polarity. Curr Opin Cell Biol 2003;15:40-47.
54. Tanoue T, Nishida E: Molecular recognitions in the MAP kinase cascades. Cell Signal 2003;15:455-462.